Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published Literature.

Adv Hematol · 2016 · PMC4826912 · PMID 27118973

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

While no significant difference was seen in the incidence of acute GVHD between the two groups, a strong trend towards less extensive chronic GVHD was seen for patients receiving 2 doses as compared with one dose of posttransplant Cy [ 25 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.